Two Sigma Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-75,181
| Closed | -$3.61M | – | 2669 |
|
|
2020
Q1 | $3.61M | Sell |
75,181
-9,619
| -11% | -$462K | 0.01% | 842 |
|
|
2019
Q4 | $3.98M | Sell |
84,800
-16,900
| -17% | -$793K | 0.01% | 939 |
|
|
2019
Q3 | $2.41M | Buy |
101,700
+9,000
| +10% | +$213K | 0.01% | 1035 |
|
|
2019
Q2 | $2.79M | Buy |
92,700
+20,200
| +28% | +$607K | 0.01% | 1062 |
|
|
2019
Q1 | $1.62M | Buy |
72,500
+26,800
| +59% | +$600K | ﹤0.01% | 1311 |
|
|
2018
Q4 | $832K | Buy |
45,700
+4,000
| +10% | +$72.8K | ﹤0.01% | 1570 |
|
|
2018
Q3 | $754K | Sell |
41,700
-18,900
| -31% | -$342K | ﹤0.01% | 1621 |
|
|
2018
Q2 | $603K | Buy |
60,600
+43,200
| +248% | +$430K | ﹤0.01% | 1844 |
|
|
2018
Q1 | $92K | Buy |
+17,400
| New | +$92K | ﹤0.01% | 2230 |
|